An experimental chimeric hepatitis E virus vaccine elicits both local and systemic immune responses.

IF 4 2区 生物学 Q2 MICROBIOLOGY Frontiers in Microbiology Pub Date : 2024-12-24 eCollection Date: 2024-01-01 DOI:10.3389/fmicb.2024.1512018
Melisa Florencia Müller, Jacinto Sacur, Julia Matias Brancher, María Daniela Vera, Lorena Arce, María Fernanda Raya-Tonetti, Haruki Kitazawa, Julio Villena, María Guadalupe Vizoso-Pinto
{"title":"An experimental chimeric hepatitis E virus vaccine elicits both local and systemic immune responses.","authors":"Melisa Florencia Müller, Jacinto Sacur, Julia Matias Brancher, María Daniela Vera, Lorena Arce, María Fernanda Raya-Tonetti, Haruki Kitazawa, Julio Villena, María Guadalupe Vizoso-Pinto","doi":"10.3389/fmicb.2024.1512018","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The development of a hepatitis E virus (HEV) vaccine is critical, with ORF2 capsid protein as the main target. We previously demonstrated that oral coadministration of recombinant ORF2 with immunomodulatory bacterium-like-particles (IBLP) induces a specific immune response in mice, particularly using IBLP derived from <i>Lacticaseibacillus rhamnosus</i> IBL027 (IBLP027), which was effective in eliciting a local humoral response. IBLP are non-live bacteria with adjuvant and carrier properties, serving as a platform for exposing proteins or antigens fused to LysM (lysine motif) domains, protein modules that bind to cell wall polysaccharides like peptidoglycan.</p><p><strong>Materials: </strong>We cloned the most immunogenic domain of ORF2 (O2P2) fused to five LysM domains (LysM<sub>5</sub>O2P2) and displayed this chimeric protein on the surface of IBLP027 to create a prototype vaccine (IBLP027-LysM<sub>5</sub>O2P2). We evaluated its capacity to induce an immune response <i>in vivo</i> by immunizing mice with three doses of either the experimental vaccine or the chimeric protein alone, using an oral or a combined schedule with subcutaneous priming followed by oral boosting. Control groups received IBLP027. Sera and small intestine fluid were analyzed for humoral response, while Peyer's patches and spleen immune cells were used for ex vivo stimulation with capsid protein to assess cellular response.</p><p><strong>Results: </strong>The oral scheme failed to elicit an IgG response, but this was overcome by a subcutaneous priming dose followed by oral boosters, which led to increasing IgG titers in the combined scheme. The highest IgG titers were seen in the vaccine prototype group. Most groups produced significantly higher IgA levels in intestinal fluid, especially in those that received the oral scheme. Cellular response studies showed increased tumor necrosis factor (TNF)-α, interferon (IFN)-γ interleukin (IL)-4, and IL-17 levels in groups receiving the chimeric protein via oral or combined schedules.</p><p><strong>Conclusion: </strong>Further and continuous research is needed to better understand both the needs and expectations of students and supervisors in different academic realities, including in Veterinary Medicine schools, from which the information available on the subject is scarce.</p>","PeriodicalId":12466,"journal":{"name":"Frontiers in Microbiology","volume":"15 ","pages":"1512018"},"PeriodicalIF":4.0000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11704494/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Microbiology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.3389/fmicb.2024.1512018","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The development of a hepatitis E virus (HEV) vaccine is critical, with ORF2 capsid protein as the main target. We previously demonstrated that oral coadministration of recombinant ORF2 with immunomodulatory bacterium-like-particles (IBLP) induces a specific immune response in mice, particularly using IBLP derived from Lacticaseibacillus rhamnosus IBL027 (IBLP027), which was effective in eliciting a local humoral response. IBLP are non-live bacteria with adjuvant and carrier properties, serving as a platform for exposing proteins or antigens fused to LysM (lysine motif) domains, protein modules that bind to cell wall polysaccharides like peptidoglycan.

Materials: We cloned the most immunogenic domain of ORF2 (O2P2) fused to five LysM domains (LysM5O2P2) and displayed this chimeric protein on the surface of IBLP027 to create a prototype vaccine (IBLP027-LysM5O2P2). We evaluated its capacity to induce an immune response in vivo by immunizing mice with three doses of either the experimental vaccine or the chimeric protein alone, using an oral or a combined schedule with subcutaneous priming followed by oral boosting. Control groups received IBLP027. Sera and small intestine fluid were analyzed for humoral response, while Peyer's patches and spleen immune cells were used for ex vivo stimulation with capsid protein to assess cellular response.

Results: The oral scheme failed to elicit an IgG response, but this was overcome by a subcutaneous priming dose followed by oral boosters, which led to increasing IgG titers in the combined scheme. The highest IgG titers were seen in the vaccine prototype group. Most groups produced significantly higher IgA levels in intestinal fluid, especially in those that received the oral scheme. Cellular response studies showed increased tumor necrosis factor (TNF)-α, interferon (IFN)-γ interleukin (IL)-4, and IL-17 levels in groups receiving the chimeric protein via oral or combined schedules.

Conclusion: Further and continuous research is needed to better understand both the needs and expectations of students and supervisors in different academic realities, including in Veterinary Medicine schools, from which the information available on the subject is scarce.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一种实验性戊型肝炎病毒嵌合疫苗可引起局部和全身免疫反应。
戊型肝炎病毒(HEV)疫苗的开发至关重要,ORF2衣壳蛋白是主要靶点。我们之前证明,重组ORF2与免疫调节性细菌样颗粒(IBLP)口服共给药可诱导小鼠特异性免疫反应,特别是来自鼠李糖乳杆菌IBL027 (IBLP027)的IBLP,可有效引发局部体液反应。IBLP是具有佐剂和载体特性的非活细菌,作为暴露融合到LysM(赖氨酸基元)结构域的蛋白质或抗原的平台,LysM(赖氨酸基元)结构域是结合细胞壁多糖如肽聚糖的蛋白质模块。材料:我们克隆了ORF2最具免疫原性的结构域(O2P2)与5个LysM结构域(LysM5O2P2)融合,并将该嵌合蛋白展示在IBLP027表面,制备了原型疫苗(IBLP027-LysM5O2P2)。我们评估了其在体内诱导免疫应答的能力,分别用三剂实验性疫苗或嵌合蛋白单独免疫小鼠,使用口服或联合计划,皮下启动,然后口服增强。对照组给予IBLP027。分析血清和小肠液的体液反应,同时用衣壳蛋白体外刺激Peyer’s patches和脾脏免疫细胞来评估细胞反应。结果:口服方案未能引起IgG反应,但通过皮下启动剂量和口服增强剂克服了这一问题,导致联合方案中IgG滴度增加。疫苗原型组IgG滴度最高。大多数组在肠液中产生显著较高的IgA水平,特别是那些接受口服方案的组。细胞反应研究显示,通过口服或联合方案接受嵌合蛋白的组中肿瘤坏死因子(TNF)-α、干扰素(IFN)-γ白细胞介素(IL)-4和IL-17水平升高。结论:需要进一步和持续的研究,以更好地了解学生和导师在不同学术现实中的需求和期望,包括在兽医学院,从这一主题的信息是稀缺的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.70
自引率
9.60%
发文量
4837
审稿时长
14 weeks
期刊介绍: Frontiers in Microbiology is a leading journal in its field, publishing rigorously peer-reviewed research across the entire spectrum of microbiology. Field Chief Editor Martin G. Klotz at Washington State University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
期刊最新文献
Age- and sex-dependent alterations of jejunal microbiota in Fischer 344 rats fed with a high-fructose, high-fat diet: depletion of Lactobacillus intestinalis in small bowel contents. Listeria monocytogenes invasion in goat brain tissues: mechanisms of blood-brain barrier disruption and regulation of apoptosis and autophagy. Commentary: CRISPR-Cas systems against carbapenem resistance-from proof-of-concept to clinical translation. Editorial: Advancements in diversity and drug resistance mechanisms in mycobacterial diseases. Bactericidal and antibiofilm activity of lactic acid bacteria-derived cell free extracts against dairy-associated spoilage and pathogenic bacteria.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1